Chronic Venous Thrombosis

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Chronic Venous Thrombosis trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

Actively recruiting — 6 trials

RecruitingNot Applicable

NCT07219758

RECANA OUS - Recana Thrombectomy Catheter System for Venous Obstruction and Occlusion Study (RECANA-OUS-UK)

The goal of this clinical investigation is to learn if the Recana Thrombectomy Catheter System can treat chronic venous obstruction and occlusion in participant…

United Kingdom30 participantsStarted 2025-10-18

Treatment: Recana Thrombectomy Catheter System

RecruitingNot Applicable

NCT05628948

Vascular Lab Resource (VLR) Biorepository

This is a study of biomarkers obtained from prospectively collected subject samples and their correlation with cardiovascular and metabolic diseases. The purpos…

United States500 participantsStarted 2019-11-14

RecruitingNot Applicable

NCT07095660

RECANA OUS - Recana Thrombectomy Catheter System for Venous Obstruction and Occlusion Study (RECANA-OUS-IRL)

The goal of this clinical investigation is to learn if the Recana Thrombectomy Catheter System can treat chronic venous obstruction and occlusion in participant…

Ireland20 participantsStarted 2025-07-02

Treatment: Recana procedure

RecruitingPhase 4

NCT06873321

VTE Incidence After Rivaroxaban + Aspirin or SAPT After Lower-limb Revascularization

Venous thromboembolism (VTE) has a high prevalence in patients with multiple comorbidities undergoing complex surgical procedures. Sometimes, extended prophylax…

Brazil100 participantsStarted 2024-02-24

Treatment: rivaroxaban 2.5 mg bid + aspirin 100 mg, clopidogrel 75 mg od for 3 months followed by aspirin 100 mg od for endovascular procedures or aspirin for open procedures

RecruitingPhase 3

NCT05679024

Stroke Prophylaxis With Apixaban in Chronic Kidney Disease Stage 5 Patients With Atrial Fibrillation

Objective: To study the efficacy and safety of apixaban as stroke prophylaxis in patients with chronic kidney disease (CKD) stage 5 and atrial fibrillation (AF)…

Finland, Iceland, Norway1,400 participantsStarted 2023-02-17

Treatment: Apixaban 2.5 milligram Oral Tablet

RecruitingNot Applicable

NCT02219984

START-Register: Survey on Anticoagulated Patients Register

This is a phase 4 cohort prospective, open, national, multicentre study that collects data on history of patients treated chronically with anticoagulant drugs,…

Italy15,410 participantsStarted 2011-10

Treatment: Anticoagulants

All recent trials (56 shown)

Not Yet RecruitingNot Applicable

NCT07529756

The ReCAna for Lower ExtremIty Venous OBstructions and In-StEnt Restenosis Registry

The goal of this observational study is to gather additional safety and performance (effectiveness) data on the device for the treatment of symptomatic lower ex…

Location not specified87 participantsStarted 2026-06

Treatment: mechanical thrombectomy

Not Yet RecruitingPhase 4

NCT07240649

Outcomes From Hyperbaric Oxygen (HBO2) Treatment for Emerging Indications

This study will evaluate the effectiveness of hyperbaric oxygen therapy (HBOT) on treating emerging indications (i.e., conditions that have shown to potentially…

Location not specified100 participantsStarted 2026-08

Treatment: Hyperbaric oxygen treatment (HBOT), 100% Oxygen

Chronic Venous Thrombosis

Trial phase breakdown

Trial status

Actively recruiting — 6 trials

RECANA OUS - Recana Thrombectomy Catheter System for Venous Obstruction and Occlusion Study (RECANA-OUS-UK)

Vascular Lab Resource (VLR) Biorepository

RECANA OUS - Recana Thrombectomy Catheter System for Venous Obstruction and Occlusion Study (RECANA-OUS-IRL)

VTE Incidence After Rivaroxaban + Aspirin or SAPT After Lower-limb Revascularization

Stroke Prophylaxis With Apixaban in Chronic Kidney Disease Stage 5 Patients With Atrial Fibrillation

START-Register: Survey on Anticoagulated Patients Register

All recent trials (56 shown)

The ReCAna for Lower ExtremIty Venous OBstructions and In-StEnt Restenosis Registry

Outcomes From Hyperbaric Oxygen (HBO2) Treatment for Emerging Indications

Trial phase breakdown

Trial status

Actively recruiting — 6 trials

RECANA OUS - Recana Thrombectomy Catheter System for Venous Obstruction and Occlusion Study (RECANA-OUS-UK)

Vascular Lab Resource (VLR) Biorepository

RECANA OUS - Recana Thrombectomy Catheter System for Venous Obstruction and Occlusion Study (RECANA-OUS-IRL)

VTE Incidence After Rivaroxaban + Aspirin or SAPT After Lower-limb Revascularization

Stroke Prophylaxis With Apixaban in Chronic Kidney Disease Stage 5 Patients With Atrial Fibrillation

START-Register: Survey on Anticoagulated Patients Register

All recent trials (56 shown)

The ReCAna for Lower ExtremIty Venous OBstructions and In-StEnt Restenosis Registry

Outcomes From Hyperbaric Oxygen (HBO2) Treatment for Emerging Indications

Venous Thromboembolism and Chronic Pain After Major Limb Trauma

Case-Specific Health Care Professional Clinical Survey of Liberant™ Thrombectomy System

Low-Dose Apixaban Added to Standard Heparin Lock Versus Heparin Lock Alone to Prevent Tunneled Hemodialysis Catheters Dy…

FUVID Study: Functional Characterization of Children With Chronic Venous Thromboembolic Disease

Chronic Venous Thrombosis: Relief With Adjunctive Catheter-Directed Therapy (The C-TRACT Trial)

ClotTriever Outcomes (CLOUT) Registry

Best Endovenous Treatment, Including STenting, Versus Non-endovenous Treatment in Chronic Proximal Deep Venous Disease

Primary Care-Hospital Embedding: a Prospective, Multicentric, Observational Study

Venous Stent for the Iliofemoral Vein Investigational Clinical Trial Using the DUO Venous Stent System

Thrombosis Outcomes in Pediatric Venous Thromboembolism

The Effect of Prophylactic Anticoagulation on Major Bleeding Events in Hospitalized Chronic Kidney Disease and Lower Lim…

The Safety and Effectiveness of Warfarin Vs Apixaban in Patients With NVAF/ VTE and ESKD on Dialysis

Donor Specific HLA Alloantibodies in Liver Transplantation

Intensive Versus Standard Hemodialysis CVC Dysfunction Protocol

VALUE- Vascular Access Laminate eUropean Experience. A Post Market Surveillance Study to Assess the Safety and Effective…

Surfacer System to Facilitate Access in Venous Occlusions

The MUFFIN-PTS Trial

Risk Factors and Management Outcome of Chronic Portal Vein Thrombosis in Children